NCT02142881View on ClinicalTrials.gov

Treatment of Masked Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 7, 2017

Study Completion Date

December 7, 2017

Conditions
Masked HypertensionHypertensionChronic Renal Insufficiency
Interventions
OTHER

Antihypertensive medication intensification

Antihypertensive medications will be adjusted by study staff based on ambulatory and clinic BP results at baseline and 2 months with a target 24hr systolic blood pressure of \<130 mmHg.

OTHER

Usual care

Antihypertensive medications will be adjusted by the participants' providers (usual care).

Trial Locations (1)

55414

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02142881 - Treatment of Masked Hypertension | Biotech Hunter | Biotech Hunter